デフォルト表紙
市場調査レポート
商品コード
1075527

マウスモデルの世界市場 (2021年~2028年):産業分析・規模・シェア・成長・動向・予測

Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

出版日: | 発行: Transparency Market Research | ページ情報: 英文 155 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
マウスモデルの世界市場 (2021年~2028年):産業分析・規模・シェア・成長・動向・予測
出版日: 2022年03月24日
発行: Transparency Market Research
ページ情報: 英文 155 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のマウスモデルの市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 仮定・調査手法

第3章 エグゼクティブサマリー:世界のマウスモデル市場

第4章 市場概要

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界市場分析・予測
    • 市場収益予測

第5章 重要洞察

  • 産業における主な展開
  • 市場概要
  • 技術の進歩
  • COVID-19の影響

第6章 世界のマウスモデル市場の分析・予測:タイプ別

  • イントロダクション・定義
  • 主な調査結果・展開
  • 市場規模の予測
    • トランスジェニックマウスモデル
    • ハイブリッド/コンジェニックマウスモデル
    • ノックアウトマウスモデル
    • 発がん物質誘発性および自発性マウスモデル
    • 非近交系マウスモデル
    • 近交系マウスモデル
    • 移植マウスモデル
    • 条件付け/外科的修正マウスモデル
  • 市場の魅力

第7章 世界のマウスモデル市場の分析・予測:専門領域別

  • イントロダクション・定義
  • 主な調査結果・展開
  • 市場規模の予測
    • 免疫
    • 中枢神経系(CNS)
    • 腫瘍
    • 心臓血管
    • 糖尿病
    • 代謝・調節
  • 市場の魅力

第8章 世界のマウスモデル市場の分析・予測:サービス別

  • イントロダクション・定義
  • 主な調査結果・展開
  • 市場規模の予測
    • 繁殖および再誘導体化サービス
    • 凍結保存および凍結回収サービス
    • 検疫サービス
    • 遺伝子検査サービス
    • モデル導入サービス
    • InVivoおよびInVitro薬理サービス
    • 遺伝子操作モデルサービス
    • その他(外科およびラインレスキュー)
  • 市場の魅力

第9章 世界のマウスモデル市場の分析・予測:地域別

  • 主な調査結果
  • 市場規模の予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力

第10章 北米のマウスモデル市場の分析・予測

第11章 欧州のマウスモデル市場の分析・予測

第12章 アジア太平洋マウスモデル市場の分析・予測

第13章 ラテンアメリカのマウスモデル市場の分析・予測

第14章 中東およびアフリカのマウスモデル市場の分析・予測

第15章 競合情勢

  • 参入事業者:競合マトリックス(企業ティア・規模別)
  • 企業プロファイル
    • Charles River Laboratories International, Inc.
    • Crescendo Biologics Limited
    • Deltagen, Inc.
    • genOway SA
    • Harbour Antibodies BV
    • Harlan Laboratories, Inc.
    • ImmunoGenes AG
    • The Jackson Laboratory
    • Taconic Biosciences, Inc.
    • TransGenic, Inc.
図表

List of Tables

  • Table 01: Global Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 03: Global Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031
  • Table 04: Global Mice Model Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Mice Model Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 07: North America Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 08: North America Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031
  • Table 09: Europe Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Europe Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 12: Europe Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031
  • Table 13: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 16: Europe Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031
  • Table 17: Latin America Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 19: Latin America Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 20: Latin America Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031
  • Table 21: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017-2031
  • Table 24: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Services, 2017-2031

List of Figures

  • Figure 01: Global Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 02: Global Mice Model Market Value Share, by Type, 2020
  • Figure 03: Global Mice Model Market Value Share, by Specialty, 2020
  • Figure 04: Global Mice Model Market Value Share, by Services, 2020
  • Figure 05: Global Mice Model Market Value Share, by Region, 2020
  • Figure 06: Global Mice Model Market, by Type, 2017 and 2028
  • Figure 07: Global Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 08: Global Mice Model Market (US$ Mn), by Transgenic Mice Model, 2017-2028
  • Figure 09: Global Mice Model Market (US$ Mn), by Hybrid/Congenic Mice Model, 2017-2028
  • Figure 10: Global Mice Model Market (US$ Mn), by Knockout Mice Model, 2017-2028
  • Figure 11: Global Mice Model Market (US$ Mn), by Carcinogen-induced & Spontaneous Mice Model, 2017-2028
  • Figure 12: Global Mice Model Market (US$ Mn), by Outbred Mice Model, 2017-2028
  • Figure 13: Global Mice Model Market (US$ Mn), by Inbred Mice Model, 2017-2028
  • Figure 14: Global Mice Model Market (US$ Mn), by Transplantation Mice Model, 2017-2028
  • Figure 15: Global Mice Model Market (US$ Mn), by Conditioned/Surgically Modified Mice Model, 2017-2028
  • Figure 16: Global Mice Model Market, by Specialty, 2017 and 2028
  • Figure 17: Global Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 18: Global Mice Model Market (US$ Mn), by Immunology, 2017-2028
  • Figure 19: Global Mice Model Market (US$ Mn), by Central Nervous System (CNS), 2017-2028
  • Figure 20: Global Mice Model Market (US$ Mn), by Oncology, 2017-2028
  • Figure 21: Global Mice Model Market (US$ Mn), by Cardiovascular, 2017-2028
  • Figure 22: Global Mice Model Market (US$ Mn), by Diabetes, 2017-2028
  • Figure 23: Global Mice Model Market Attractiveness Analysis, by Services, 2020-2028
  • Figure 24: Global Mice Model Market (US$ Mn), by Cryopreservation & Cryorecovery Services, 2017-2028
  • Figure 25: Global Mice Model Market (US$ Mn), by Quarantine Services, 2017-2028
  • Figure 26: Global Mice Model Market (US$ Mn), by Genetic Testing Services, 2017-2028
  • Figure 27: Global Mice Model Market (US$ Mn), by Model In-licensing Services, 2017-2028
  • Figure 28: Global Mice Model Market (US$ Mn), by In Vivo & In Vitro Pharmacology Services, 2017-2028
  • Figure 29: Global Mice Model Market (US$ Mn), by Genetically Engineered Model Services, 2017-2028
  • Figure 30: Global Mice Model Market (US$ Mn), Other services (surgical and line rescue), 2017-2028
  • Figure 31: North America Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 32: North America Mice Model Market Value Share Analysis, by Country, 2017 and 2028
  • Figure 33: North America Mice Model Market, by Type, 2017 and 2028
  • Figure 34: North America Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 35: North America Mice Model Market, by Specialty, 2017 and 2028
  • Figure 36: North America Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 37: North America Mice Model Market, by Services, 2017 and 2028
  • Figure 38: North America Mice Model Market Attractiveness Analysis, by Services, 2020-2028
  • Figure 39: Europe Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 40: Europe Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028
  • Figure 41: Europe Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020-2028
  • Figure 42: Europe Mice Model Market, by Type, 2017 and 2028
  • Figure 43: Europe Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 44: Europe Mice Model Market, by Specialty, 2017 and 2028
  • Figure 45: Europe Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 46: Europe Mice Model Market, by Services, 2017 and 2028
  • Figure 47: Europe Mice Model Market Attractiveness Analysis, by Services, 2020-2028
  • Figure 48: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 49: Asia Pacific Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028
  • Figure 50: Asia Pacific Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020-2028
  • Figure 51: Asia Pacific Mice Model Market, by Type, 2017 and 2028
  • Figure 52: Asia Pacific Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 53: Asia Pacific Mice Model Market, by Specialty, 2017 and 2028
  • Figure 54: Asia Pacific Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 55: Asia Pacific Mice Model Market, by Services, 2017 and 2028
  • Figure 56: Asia Pacific Mice Model Market Attractiveness Analysis, by Services, 2020-2028
  • Figure 57: Latin America Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 58: Latin America Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028
  • Figure 59: Latin America Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020-2028
  • Figure 60: Latin America Mice Model Market, by Type, 2017 and 2028
  • Figure 61: Latin America Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 62: Latin America Mice Model Market, by Specialty, 2017 and 2028
  • Figure 63: Latin America Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 64: Latin America Mice Model Market, by Services, 2017 and 2028
  • Figure 65: Latin America Mice Model Market Attractiveness Analysis, by Services, 2020-2028
  • Figure 66: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, 2017-2028
  • Figure 67: Middle East & Africa Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028
  • Figure 68: Middle East & Africa Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020-2028
  • Figure 69: Middle East & Africa Mice Model Market, by Type, 2017 and 2028
  • Figure 70: Middle East & Africa Mice Model Market Attractiveness Analysis, by Type, 2020-2028
  • Figure 71: Middle East & Africa Mice Model Market, by Specialty, 2017 and 2028
  • Figure 72: Middle East & Africa Mice Model Market Attractiveness Analysis, by Specialty, 2020-2028
  • Figure 73: Middle East & Africa Mice Model Market, by Services, 2017 and 2028
  • Figure 74: Middle East & Africa Mice Model Market Attractiveness Analysis, by Services, 2020-2028
目次
Product Code: TMRGL2085

Mice Model Market - Scope of Report

TMR's report on the global mice model market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global mice model market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global mice model market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global mice model market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global mice model market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global mice model market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global mice model market.

The report delves into the competitive landscape of the global mice model market. Key players operating in the global mice model market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global mice model market that have been profiled in this report.

Key Questions Answered in Mice Model Market Report

What is the scope of growth of product companies in the global mice model market?

What will be the Y-o-Y growth of the global mice model market between 2019 and 2028?

What is the influence of changing trends in technologies on the global mice model market?

Will North America be the most profitable market for mice model providers?

Which factors are anticipated to hamper the growth of the global mice model market during the forecast period?

Which are the leading companies in the global mice model market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global mice model market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global mice model market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the mice model market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the mice model market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global mice model market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global mice model market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mice Model Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mice Model Market Analysis and Forecast, 2017-2028
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Developments
  • 5.2. Overview of Mice Model Market
  • 5.3. Technological Advancements
  • 5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Mice Model Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2028
    • 6.3.1. Transgenic Mice Model
    • 6.3.2. Hybrid/Congenic Mice Model
    • 6.3.3. Knockout Mice Model
    • 6.3.4. Carcinogen-induced & Spontaneous Mice Model
    • 6.3.5. Outbred Mice Model
    • 6.3.6. Inbred Mice Model
    • 6.3.7. Transplantation Mice Model
    • 6.3.8. Conditioned/Surgically Modified Mice Model
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Mice Model Market Analysis and Forecast, by Specialty

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Specialty, 2017-2028
    • 7.3.1. Immunology
    • 7.3.2. Central Nervous System (CNS)
    • 7.3.3. Oncology
    • 7.3.4. Cardiovascular
    • 7.3.5. Diabetes
    • 7.3.6. Metabolism & Regulation
  • 7.4. Market Attractiveness Analysis, by Specialty

8. Global Mice Model Market Analysis and Forecast, by Services

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Services, 2017-2028
    • 8.3.1. Breeding & Rederivation Services
    • 8.3.2. Cryopreservation & Cryorecovery Services
    • 8.3.3. Quarantine Services
    • 8.3.4. Genetic Testing Services
    • 8.3.5. Model In-licensing Services
    • 8.3.6. In Vivo & In Vitro Pharmacology Services
    • 8.3.7. Genetically Engineered Model Services
    • 8.3.8. Other Services (surgical and line rescue)
  • 8.4. Market Attractiveness Analysis, by Services

9. Global Mice Model Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Country/Region

10. North America Mice Model Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2028
    • 10.2.1. Transgenic Mice Model
    • 10.2.2. Hybrid/Congenic Mice Model
    • 10.2.3. Knockout Mice Model
    • 10.2.4. Carcinogen-induced & Spontaneous Mice Model
    • 10.2.5. Outbred Mice Model
    • 10.2.6. Inbred Mice Model
    • 10.2.7. Transplantation Mice Model
    • 10.2.8. Conditioned/Surgically Modified Mice Model
  • 10.3. Market Value Forecast, by Specialty, 2017-2028
    • 10.3.1. Immunology
    • 10.3.2. Central Nervous System (CNS)
    • 10.3.3. Oncology
    • 10.3.4. Cardiovascular
    • 10.3.5. Diabetes
    • 10.3.6. Metabolism & Regulation
  • 10.4. Market Value Forecast, by Services, 2017-2028
    • 10.4.1. Breeding & Rederivation Services
    • 10.4.2. Cryopreservation & Cryorecovery Services
    • 10.4.3. Quarantine Services
    • 10.4.4. Genetic Testing Services
    • 10.4.5. Model In-licensing Services
    • 10.4.6. In Vivo & In Vitro Pharmacology Services
    • 10.4.7. Genetically Engineered Model Services
    • 10.4.8. Other Services (surgical and line rescue)
  • 10.5. Market Value Forecast, by Country, 2017-2028
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Specialty
    • 10.6.3. By Services
    • 10.6.4. By Country

11. Europe Mice Model Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2028
    • 11.2.1. Transgenic Mice Model
    • 11.2.2. Hybrid/Congenic Mice Model
    • 11.2.3. Knockout Mice Model
    • 11.2.4. Carcinogen-induced & Spontaneous Mice Model
    • 11.2.5. Outbred Mice Model
    • 11.2.6. Inbred Mice Model
    • 11.2.7. Transplantation Mice Model
    • 11.2.8. Conditioned/Surgically Modified Mice Model
  • 11.3. Market Value Forecast, by Specialty, 2017-2028
    • 11.3.1. Immunology
    • 11.3.2. Central Nervous System (CNS)
    • 11.3.3. Oncology
    • 11.3.4. Cardiovascular
    • 11.3.5. Diabetes
    • 11.3.6. Metabolism & Regulation
  • 11.4. Market Value Forecast, by Services, 2017-2028
    • 11.4.1. Breeding & Rederivation Services
    • 11.4.2. Cryopreservation & Cryorecovery Services
    • 11.4.3. Quarantine Services
    • 11.4.4. Genetic Testing Services
    • 11.4.5. Model In-licensing Services
    • 11.4.6. In Vivo & In Vitro Pharmacology Services
    • 11.4.7. Genetically Engineered Model Services
    • 11.4.8. Other Services (surgical and line rescue)
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Specialty
    • 11.6.3. By Services
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Mice Model Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2028
    • 12.2.1. Transgenic Mice Model
    • 12.2.2. Hybrid/Congenic Mice Model
    • 12.2.3. Knockout Mice Model
    • 12.2.4. Carcinogen-induced & Spontaneous Mice Model
    • 12.2.5. Outbred Mice Model
    • 12.2.6. Inbred Mice Model
    • 12.2.7. Transplantation Mice Model
    • 12.2.8. Conditioned/Surgically Modified Mice Model
  • 12.3. Market Value Forecast, by Specialty, 2017-2028
    • 12.3.1. Immunology
    • 12.3.2. Central Nervous System (CNS)
    • 12.3.3. Oncology
    • 12.3.4. Cardiovascular
    • 12.3.5. Diabetes
    • 12.3.6. Metabolism & Regulation
  • 12.4. Market Value Forecast, by Services, 2017-2028
    • 12.4.1. Breeding & Rederivation Services
    • 12.4.2. Cryopreservation & Cryorecovery Services
    • 12.4.3. Quarantine Services
    • 12.4.4. Genetic Testing Services
    • 12.4.5. Model In-licensing Services
    • 12.4.6. In Vivo & In Vitro Pharmacology Services
    • 12.4.7. Genetically Engineered Model Services
    • 12.4.8. Other Services (surgical and line rescue)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Specialty
    • 12.6.3. By Services
    • 12.6.4. By Country/Sub-region

13. Latin America Mice Model Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type , 2017-2028
    • 13.2.1. Transgenic Mice Model
    • 13.2.2. Hybrid/Congenic Mice Model
    • 13.2.3. Knockout Mice Model
    • 13.2.4. Carcinogen-induced & Spontaneous Mice Model
    • 13.2.5. Outbred Mice Model
    • 13.2.6. Inbred Mice Model
    • 13.2.7. Transplantation Mice Model
    • 13.2.8. Conditioned/Surgically Modified Mice Model
  • 13.3. Market Value Forecast, by Specialty, 2017-2028
    • 13.3.1. Immunology
    • 13.3.2. Central Nervous System (CNS)
    • 13.3.3. Oncology
    • 13.3.4. Cardiovascular
    • 13.3.5. Diabetes
    • 13.3.6. Metabolism & Regulation
  • 13.4. Market Value Forecast, by Services, 2017-2028
    • 13.4.1. Breeding & Rederivation Services
    • 13.4.2. Cryopreservation & Cryorecovery Services
    • 13.4.3. Quarantine Services
    • 13.4.4. Genetic Testing Services
    • 13.4.5. Model In-licensing Services
    • 13.4.6. In Vivo & In Vitro Pharmacology Services
    • 13.4.7. Genetically Engineered Model Services
    • 13.4.8. Other Services (surgical and line rescue)
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Specialty
    • 13.6.3. By Services
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Mice Model Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2028
    • 14.2.1. Transgenic Mice Model
    • 14.2.2. Hybrid/Congenic Mice Model
    • 14.2.3. Knockout Mice Model
    • 14.2.4. Carcinogen-induced & Spontaneous Mice Model
    • 14.2.5. Outbred Mice Model
    • 14.2.6. Inbred Mice Model
    • 14.2.7. Transplantation Mice Model
    • 14.2.8. Conditioned/Surgically Modified Mice Model
  • 14.3. Market Value Forecast, by Specialty, 2017-2028
    • 14.3.1. Immunology
    • 14.3.2. Central Nervous System (CNS)
    • 14.3.3. Oncology
    • 14.3.4. Cardiovascular
    • 14.3.5. Diabetes
    • 14.3.6. Metabolism & Regulation
  • 14.4. Market Value Forecast, by Services, 2017-2028
    • 14.4.1. Breeding & Rederivation Services
    • 14.4.2. Cryopreservation & Cryorecovery Services
    • 14.4.3. Quarantine Services
    • 14.4.4. Genetic Testing Services
    • 14.4.5. Model In-licensing Services
    • 14.4.6. In Vivo & In Vitro Pharmacology Services
    • 14.4.7. Genetically Engineered Model Services
    • 14.4.8. Other Services (surgical and line rescue)
  • 14.5. Market Value Forecast, by Country, 2017-2028
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Specialty
    • 14.6.3. By Services
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Charles River Laboratories International, Inc.
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Crescendo Biologics Limited
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. Deltagen, Inc.
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. genOway S.A.
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Harbour Antibodies BV
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. Harlan Laboratories, Inc.
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. ImmunoGenes AG
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
    • 15.2.8. The Jackson Laboratory
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Business Strategies
      • 15.2.8.5. Recent Developments
    • 15.2.9. Taconic Biosciences, Inc.
      • 15.2.9.1. Company Overview
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Business Strategies
      • 15.2.9.5. Recent Developments
    • 15.2.10. TransGenic, Inc.
      • 15.2.10.1. Company Overview
      • 15.2.10.2. Financial Overview
      • 15.2.10.3. Product Portfolio
      • 15.2.10.4. Business Strategies
      • 15.2.10.5. Recent Developments